Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective

The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Cavenagh, Jamie, Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Kropff, Martin, Leal da Costa, Fernando, Louw, Vernon, Magen-Nativ, Hila, Mendeleeva, Larisa, Nahi, Hareth, Plesner, Torben, San-Miguel, Jesús, Sonneveld, Pieter, Udvardy, Miklos, Sondergeld, Pia, Palumbo, Antonio
Format: Artigo
Sprache:Inglês
Veröffentlicht: AlphaMed Press 2011
Schlagworte:
Academia-Pharma Intersect
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228121/
https://ncbi.nlm.nih.gov/pubmed/21441574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0386
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge